Emerging Role and Therapeutic Implication of Wnt Signaling Pathways in Autoimmune Diseases

Journal of Immunology Research

Volumn 2016, Issue , 2016, Pages

  Shi, Juan ^a   Chi, Shuhong ^a   Xue, Jing ^b   Yang, Jiali ^a   Li, Feng ^a   Liu, Xiaoming ^a,b  

^a NINGXIA MEDICAL UNIVERSITY   (China)

^b NINGXIA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; AXIN; AXIN1 PROTEIN, HUMAN; BETA CATENIN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3BETA; WNT PROTEIN;

ANKYLOSING SPONDYLITIS; AUTOIMMUNE DISEASE; CELL ACTIVATION; HUMAN; INFLAMMATORY BOWEL DISEASE; NONHUMAN; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; WNT SIGNALING PATHWAY; ANIMAL; DISEASE MODEL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; PATHOLOGY; SYSTEMIC SCLEROSIS;

ANIMALS; AXIN PROTEIN; BETA CATENIN; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; HUMANS; INFLAMMATORY BOWEL DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICRORNAS; SCLERODERMA, SYSTEMIC; SPONDYLITIS, ANKYLOSING; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84971462210     PISSN: 23148861     EISSN: 23147156     Source Type: Journal    
DOI: 10.1155/2016/9392132     Document Type: Review

References (152)

1. M. Wahren-Herlenius and T. Dörner, "Immunopathogenic mechanisms of systemic autoimmune disease, " The Lancet, vol. 382, no. 9894, pp. 819-831, 2013.
2. T. Koutsokeras and T. Healy, "Systemic lupus erythematosus and lupus nephritis, " Nature Reviews Drug Discovery, vol. 13, no. 3, pp. 173-174, 2014.
3. R. A. Benson, J. M. Brewer, and A. M. Platt, "Mechanisms of autoimmunity in human diseases: a critical review of current dogma, " Current Opinion in Rheumatology, vol. 26, no. 2, pp. 197-203, 2014.
4. M. D. Rosenblum, K. A. Remedios, and A. K. Abbas, "Mechanisms of human autoimmunity, " Journal of Clinical Investigation, vol. 125, no. 6, pp. 2228-2233, 2015.
5. R. Nusse, "Cell signalling: disarmingWnt, " Nature, vol. 519, no. 7542, pp. 163-164, 2015.
6. S. M. Hauck, F. Hofmaier, J. Dietter et al., "Label-free LCMSMS analysis of vitreous from autoimmune uveitis reveals a significant decrease in secretedWnt signalling inhibitors DKK3 and SFRP2, " Journal of Proteomics, vol. 75, no. 14, pp. 4545-4554, 2012.
7. G. Schett, J. Zwerina, and J.-P. David, "The role ofWnt proteins in arthritis, " Nature Clinical Practice Rheumatology, vol. 4, no. 9, pp. 473-480, 2008.
8. A. A. Tveita andO. P. Rekvig, "Alterations inWntpathway activity in mouse serum and kidneys during lupus development, " Arthritis and Rheumatism, vol. 63, no. 2, pp. 513-522, 2011.
9. C. Beyer, A. Schramm, A. Akhmetshina et al., "-catenin is a central mediator of pro-fibrotic Wnt signaling in systemic sclerosis, " Annals of the Rheumatic Diseases, vol. 71, no. 5, pp. 761-767, 2012.
10. R. T. Moon, A. D. Kohn, G. V. De Ferrari, and A. Kaykas, "WNT and-catenin signalling: diseases and therapies, " Nature Reviews Genetics, vol. 5, no. 9, pp. 691-701, 2004.
11. X.-D. Wang, X.-F. Huang, Q.-R. Yan, and C.-D. Bao, "Aberrant activation of the WNT/-catenin signaling pathway in lupus nephritis, " PLoS ONE, vol. 9, no. 1, Article ID e84852, 2014.
12. S. Yuan, Y. Shi, and S.-J. Tang, "Wnt signaling in the pathogenesis ofmultiple sclerosis-associated chronic pain, " Journal of Neuroimmune Pharmacology, vol. 7, no. 4, pp. 904-913, 2012.
13. Y. Komiya and R. Habas, "Wnt signal transduction pathways, " Organogenesis, vol. 4, no. 2, pp. 68-75, 2008.
14. K. Yang, X. Wang, H. Zhang et al., "The evolving roles of canonical WNT signaling in stem cells and tumorigenesis: implications in targeted cancer therapies, " Laboratory Investigation, vol. 96, no. 2, pp. 116-136, 2016.
15. D. Tai, K. Wells, J. Arcaroli et al., "Targeting theWNT signaling pathway in cancer therapeutics, " Oncologist, vol. 20, no. 10, pp. 1189-1198, 2015.
16. Y. F. Xiao, X. Yong, B. Tang et al., "Notch and Wnt signaling pathway in cancer: crucial role and potential therapeutic targets (review), " International Journal of Oncology, vol. 48, no. 2, pp. 437-449, 2015.
17. M. Corr, "Wnt signaling in ankylosing spondylitis, " Clinical Rheumatology, vol. 33, no. 6, pp. 759-762, 2014.
18. M. Sen, J. Reifert, K. Lauterbach et al., "Regulation of fibronectin and metalloproteinase expression byWnt signaling in rheumatoid arthritis synoviocytes, " Arthritis and Rheumatism, vol. 46, no. 11, pp. 2867-2877, 2002.
19. J. Wei, D. Melichian, K. Komura et al., "CanonicalWnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mousemodel for scleroderma" Arthritis and Rheumatism, vol. 63, no. 6, pp. 1707-1717, 2011.
20. A. Tury, K. Tolentino, and Y. Zou, "Altered expression of atypical PKC and Ryk in the spinal cord of a mouse model of amyotrophic lateral sclerosis, " Developmental Neurobiology, vol. 74, no. 8, pp. 839-850, 2014.
21. K. Tamai, M. Semenov, Y. Kato et al., "LDL-receptor-related proteins inWnt signal transduction, " Nature, vol. 407, no. 6803, pp. 530-535, 2000.
22. R. T. Moon, B. Bowerman, M. Boutros, and N. Perrimon, "The promise and perils ofWnt signaling through-catenin, " Science, vol. 296, no. 5573, pp. 1644-1646, 2002.
23. C. Niehrs, "The complex world of WNT receptor signalling, " Nature Reviews Molecular Cell Biology, vol. 13, no. 12, pp. 767-779, 2012.
24. E. Gómez-Orte, B. Sáenz-Narciso, S. Moreno, and J. Cabello, "Multiple functions of the noncanonical Wnt pathway, " Trends in Genetics, vol. 29, no. 9, pp. 545-553, 2013.
25. M. T. Veeman, J. D. Axelrod, and R. T. Moon, "A second canon: functions and mechanisms of-catenin-independent Wnt signaling, " Developmental Cell, vol. 5, no. 3, pp. 367-377, 2003.
26. A. Kikuchi, H. Yamamoto, A. Sato, and S. Matsumoto, "New insights into the mechanism of Wnt signaling pathway activation, " International Review of Cell and Molecular Biology, vol. 291, pp. 21-71, 2011.
27. T. Malinauskas and E. Y. Jones, "Extracellular modulators of Wnt signalling, " Current Opinion in Structural Biology, vol. 29, pp. 77-84, 2014.
28. C. Niehrs, "Function and biological roles of the Dickkopf family of Wnt modulators, " Oncogene, vol. 25, no. 57, pp. 7469-7481, 2006.
29. B. Mao and C. Niehrs, "Kremen2 modulates Dickkopf2 activity duringWnt/LRP6 signaling, " Gene, vol. 302, no. 1-2, pp. 179-183, 2003.
30. L. Liang, H. He, R. Lv et al., "Preliminary mechanism on the methylationmodification of Dkk-1 and Dkk-3 in hepatocellular carcinoma, " Tumor Biology, vol. 36, no. 2, pp. 1245-1250, 2015.
31. L. Gattinoni, X.-S. Zhong, D. C. Palmer et al., "Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stemcells, " Nature Medicine, vol. 15, no. 7, pp. 808-813, 2009.
32. D. Swafford and S. Manicassamy, "Wnt signaling in dendritic cells: its role in regulation ofimmunity and tolerance, " Discovery Medicine, vol. 19, no. 105, pp. 303-310, 2015.
33. M. J. Koslowski, Z. Teltschik, J. Beisner et al., "Association of a functional variant in the wnt co-receptor LRP6 with early onset ileal Crohn's disease, " PLoS Genetics, vol. 8, no. 2, Article ID e1002523, 2012.
34. C.-G. Miao, C. Huang, Y. Huang et al., "MeCP2 modulates the canonical Wnt pathway activation by targeting SFRP4 in rheumatoid arthritis fibroblast-like synoviocytes in rats, " Cellular Signalling, vol. 25, no. 3, pp. 598-608, 2013.
35. C. G. Miao, D. Qin, C. L. Du et al., "DNMT1 activates the canonicalWnt signaling in rheumatoid arthritismodel rats via a crucial functional crosstalk between miR-152 and the DNMT1, MeCP2, " International Immunopharmacology, vol. 28, no. 1, pp. 344-353, 2015.
36. A. Ahmadzadeh, F. Norozi, S. Shahrabi, M. Shahjahani, and N. Saki, "Wnt/-catenin signaling in bonemarrow niche, " Cell and Tissue Research, vol. 363, no. 2, pp. 321-335, 2016.
37. F. J. T. Staal, T. C. Luis, and M. M. Tiemessen, "WNT signalling in the immune system: WNT is spreading its wings, " Nature Reviews Immunology, vol. 8, no. 8, pp. 581-593, 2008.
38. B. M. Abidin, E. O. Kwarteng, and K. M. Heinonen, "Frizzled-6 regulates hematopoietic stem/progenitor cell survival and selfrenewal, " Journal of Immunology, vol. 195, no. 5, pp. 2168-2176, 2015.
39. J. Ma, R. Wang, X. Fang, and Z. Sun, "-catenin/TCF-1 pathway in T cell development and differentiation, " Journal of Neuroimmune Pharmacology, vol. 7, no. 4, pp. 750-762, 2012.
40. H. Ye, J. Zhang, J. Wang et al., "CD4 T-cell transcriptome analysis reveals aberrant regulation of STAT3 andWnt signaling pathways in rheumatoid arthritis: evidence from a case-control study, " Arthritis Research and Therapy, vol. 17, article 76, 2015.
41. Y. Ding, S. Shen, A. C. Lino, M. A. Curotto De Lafaille, and J. J. Lafaille, "Beta-catenin stabilization extends regulatory T cell survival and induces anergy in nonregulatory T cells, " Nature Medicine, vol. 14, no. 2, pp. 162-169, 2008.
42. J. vanLoosdregt, V. Fleskens, M. Tiemessen et al., "Canonical WNT signaling negatively modulates regulatory T cell function, " Immunity, vol. 39, no. 2, pp. 298-310, 2013.
43. S. Kotake and Y. Nanke, "Effect of TNF on osteoblastogenesis from mesenchymal stem cells, " Biochimica et Biophysica Acta-General Subjects, vol. 1840, no. 3, pp. 1209-1213, 2014.
44. Y. Choi, J. R. Arron, and M. J. Townsend, "Promising bonerelated therapeutic targets for rheumatoid arthritis, " Nature Reviews Rheumatology, vol. 5, no. 10, pp. 543-548, 2009.
45. J. J. Pinzone, B. M. Hall, N. K. Thudi et al., "The role ofDickkopf-1 in bone development, homeostasis, and disease, " Blood, vol. 113, no. 3, pp. 517-525, 2009.
46. H. Cheon, D. L. Boyle, and G. S. Firestein, "Wnt1 inducible signaling pathway protein-3 regulation and microsatellite structure in arthritis, " Journal of Rheumatology, vol. 31, no. 11, pp. 2106-2114, 2004.
47. M. Sen, M. Chamorro, J. Reifert, M. Corr, and D. A. Carson, "Blockade of Wnt-5A/Frizzled 5 signaling inhibits rheumatoid synoviocyte activation, " Arthritis and Rheumatism, vol. 44, no. 4, pp. 772-781, 2001.
48. Y. Nakamura, M. Nawata, and S. Wakitani, "Expression profiles and functional analyses of Wnt-related genes in human joint disorders, " American Journal of Pathology, vol. 167, no. 1, pp. 97-105, 2005.
49. S. Roser-Page, T. Vikulina, M. Zayzafoon, and M. N. Weitzmann, "CTLA-4Ig-induced T cell anergy promotes Wnt-10b production and bone formation in a mouse model, " Arthritis and Rheumatology, vol. 66, no. 4, pp. 990-999, 2014.
50. D. Daoussis, S.-N. C. Liossis, E. E. Solomou et al., "Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis, " Arthritis and Rheumatism, vol. 62, no. 1, pp. 150-158, 2010.
51. A. Briolay, P. Lencel, L. Bessueille, J. Caverzasio, R. Buchet, and D. Magne, "Autocrine stimulation of osteoblast activity by Wnt5a in response to TNF-in human mesenchymal stem cells, " Biochemical and Biophysical Research Communications, vol. 430, no. 3, pp. 1072-1077, 2013.
52. S. Assassi and M. D. Mayes, "What does global gene expression profiling tell us about the pathogenesis of systemic sclerosis?" Current Opinion in Rheumatology, vol. 25, no. 6, pp. 686-691, 2013.
53. J. Wei, F. Fang, A. P. Lam et al., "Wnt/-catenin signaling is hyperactivated in systemic sclerosis and induces Smaddependent fibrotic responses in mesenchymal cells, " Arthritis and Rheumatism, vol. 64, no. 8, pp. 2734-2745, 2012.
54. M. Antic, J. H. W. Distler, and O. Distler, "Treating skin and lung fibrosis in systemic sclerosis: a future filled with promise" Current Opinion in Pharmacology, vol. 13, no. 3, pp. 455-462, 2013.
55. S. Svegliati, G. Marrone, A. Pezone et al., "Oxidative DNA damage induces the ATM-mediated transcriptional suppression of the Wnt inhibitor WIF-1 in systemic sclerosis and fibrosis, " Science Signaling, vol. 7, no. 341, p. ra84, 2014.
56. J. Huelsken, R. Vogel, B. Erdmann, G. Cotsarelis, andW. Birchmeier, "-Catenin controls hair follicle morphogenesis and stem cell differentiation in the skin, " Cell, vol. 105, no. 4, pp. 533-545, 2001.
57. L. Suo, J. P. Sundberg, and H. B. Everts, "Dietary Vitamin A regulates wingless-related MMTV integration site signaling to alter the hair cycle, " Experimental Biology and Medicine, vol. 240, no. 5, pp. 618-623, 2015.
58. T. Fukuda, L. Chen, T. Endo et al., "Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal antigen and receptor for Wnt5a, " Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 8, pp. 3047-3052, 2008.
59. M. C. T. Novo, L. Osugui, V. O. dos Reis, I. M. Longo-Maugéri, M. Mariano, and A. F. Popi, "Blockage ofWnt/-catenin signaling by quercetin reduces survival and proliferation of B-1 cells in vitro, " Immunobiology, vol. 220, no. 1, pp. 60-67, 2015.
60. P.-P. Li, L.-L. Feng, N. Chen et al., "Metadherin contributes to the pathogenesis of chronic lymphocytic leukemia partially throughWnt/-catenin pathway, " Medical Oncology, vol. 32, no. 2, p. 479, 2015.
61. Q. M. Yao, P. P. Li, S. M. Liang et al., "Methylprednisolone suppresses the Wnt signaling pathway in chronic lymphocytic leukemia cell line MEC-1 regulated by LEF-1 expression, " International Journal of Clinical and Experimental Pathology, vol. 8, no. 7, pp. 7921-7928, 2015.
62. F. Wei, Y. Zhang, W. Zhao, X. Yu, and C.-J. Liu, "Progranulin facilitates conversion and function of regulatory T cells under inflammatory conditions, " PLoS ONE, vol. 9, no. 11, Article ID e112110, 2014.
63. C. von Toerne, C. Sieg, U. Kaufmann, M. Diedrichs-Möhring, P. J. Nelson, and G. Wildner, "Effector T cells driving monophasic vs. relapsing/remitting experimental autoimmune uveitis show unique pathway signatures, "Molecular Immunology, vol. 48, no. 1-3, pp. 272-280, 2010.
64. M. J. Koslowski, I. Kübler, M. Chamaillard et al., "Genetic variants of Wnt transcription factor TCF-4 (TCF7L2) putative promoter region are associated with small intestinal Crohn's disease, " PLoS ONE, vol. 4, no. 2, Article ID e4496, 2009.
65. J. Beisner, Z. Teltschik, M. J. Ostaff et al., "TCF-1-mediatedWnt signaling regulates Paneth cell innate immune defense effectors HD-5 and-6: implications for Crohn's disease, " American Journal of Physiology-Gastrointestinal and Liver Physiology, vol. 307, no. 5, pp. G487-G498, 2014.
66. J. R. Calabrese, A. D. Gulledge, K. Hahn et al., "Autoimmune thyroiditis in manic-depressive patients treated with lithium, " TheAmerican Journal of Psychiatry, vol. 142, no. 11, pp. 1318-1321, 1985.
67. J. E. Gudjonsson, A. Johnston, S. W. Stoll et al., "Evidence for altered Wnt signaling in psoriatic skin, " Journal of Investigative Dermatology, vol. 130, no. 7, pp. 1849-1859, 2010.
68. Z. Gu, W. Tan, G. Feng et al., "Wnt/-catenin signalingmediates the senescence of bone marrow-mesenchymal stem cells from systemic lupus erythematosus patients through the p53/p21 pathway, " Molecular and Cellular Biochemistry, vol. 387, no. 1-2, pp. 27-37, 2014.
69. R. Mussmann, M. Geese, F. Harder et al., "Inhibition of GSK3 promotes replication and survival of pancreatic beta cells, " Journal of Biological Chemistry, vol. 282, no. 16, pp. 12030-12037, 2007.
70. W. Wang, J. R. Walker, X. Wang et al., "Identification of smallmolecule inducers of pancreatic-cell expansion, " Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 5, pp. 1427-1432, 2009.
71. L. J. Vuga, A. Ben-Yehudah, E. Kovkarova-Naumovski et al., "WNT5A is a regulator of fibroblast proliferation and resistance to apoptosis, "American Journal of Respiratory Cell andMolecular Biology, vol. 41, no. 5, pp. 583-589, 2009.
72. E. Krasoudaki, A. Banos, E. Stagakis et al., "Micro-RNAanalysis of renal biopsies in human lupus nephritis demonstrates upregulated miR-422a driving reduction of kallikrein-related peptidase 4, " Nephrology Dialysis Transplantation, 2015.
73. M. Capuano, L. Iaffaldano, N. Tinto et al., "MicroRNA-449a overexpression, reduced NOTCH1 signals and scarce goblet cells characterize the small intestine of celiac patients, " PLoS ONE, vol. 6, no. 12, Article IDe29094, 2011.
74. C.-G. Miao, W.-J. Shi, Y.-Y. Xiong et al., "MicroRNA-663 activates the canonicalWnt signaling through the adenomatous polyposis coli suppression, " Immunology Letters, vol. 166, no. 1, pp. 45-54, 2015.
75. J. Sun, P. Yan, Y. Chen et al., "MicroRNA-26b inhibits cell proliferation and cytokine secretion in human RASF cells via theWnt/GSK-3/-catenin pathway, " Diagnostic Pathology, vol. 10, article 72, 2015.
76. C. Li, P. Zhang, and J. Gu, "miR-29a modulates tumor necrosis factor-induced osteogenic inhibition by targetingWnt antagonists, " Development Growth and Differentiation, vol. 57, no. 3, pp. 264-273, 2015.
77. C.-G. Miao, Y.-Y. Yang, X. He et al., "MicroRNA-152 modulates the canonical Wnt pathway activation by targeting DNA methyltransferase 1 in arthritic rat model, " Biochimie, vol. 106, pp. 149-156, 2014.
78. C.-G. Miao, W.-J. Shi, Y.-Y. Xiong et al., "MiR-375 regulates the canonicalWnt pathway through FZD8 silencing in arthritis synovial fibroblasts, " Immunology Letters, vol. 164, no. 1, pp. 1-10, 2015.
79. Y. Bao and X. Cao, "The immune potential and immunopathology of cytokine-producing B cell subsets: a comprehensive review, " Journal of Autoimmunity, vol. 55, no. 1, pp. 10-23, 2014.
80. Y. Tokuda, M. Tanaka, T. Yagi, and K. Tashiro, "The defect of SFRP2 modulates an influx of extracellular calcium in B lymphocytes, " BMC Research Notes, vol. 7, article 780, 2014.
81. S. Muralidharan, P. J. Hanley, E. Liu et al., "ActivationofWnt signaling arrests effector differentiation in human peripheral and cord blood-derived T lymphocytes, " Journal of Immunology, vol. 187, no. 10, pp. 5221-5232, 2011.
82. A. Suryawanshi, I. Manoharan, Y. Hong et al., "Canonical Wnt signaling in dendritic cells regulates Th1/Th17 responses and suppresses autoimmune neuroinflammation, " Journal of Immunology, vol. 194, no. 7, pp. 3295-3304, 2015.
83. P. M. Bhatt and R. Malgor, "Wnt5a: a player in the pathogenesis of atherosclerosis and other inflammatory disorders, " Atherosclerosis, vol. 237, no. 1, pp. 155-162, 2014.
84. J. Valencia, C. Hernández-López, V. G. Martínez et al., "Wnt5a skews dendritic cell differentiation to an unconventional phenotype with tolerogenic features, " Journal of Immunology, vol. 187, no. 8, pp. 4129-4139, 2011.
85. A. Holtzhausen, F. Zhao, K. S. Evans et al., "Melanoma-derived Wnt5a promotes local dendritic-cell expression of IDO and immunotolerance: opportunities for pharmacologic enhancement of immunotherapy, " Cancer Immunology Research, vol. 3, no. 9, pp. 1082-1095, 2015.
86. C. Oderup, M. LaJevic, and E. C. Butcher, "Canonical and noncanonicalWnt proteins programdendritic cell responses for tolerance, " Journal of Immunology, vol. 190, no. 12, pp. 6126-6134, 2013.
87. S. Manicassamy, B. Reizis, R. Ravindran et al., "Activation of-catenin in dendritic cells regulates immunity versus tolerance in the intestine, " Science, vol. 329, no. 5993, pp. 849-853, 2010.
88. J. Wienke, W. Janssen, R. Scholman et al., "A novel human STAT3 mutation presents with autoimmunity involving Th17 hyperactivation, " Oncotarget, vol. 6, no. 24, pp. 20037-20042, 2015.
89. C. Lamagna, P. Scapini, J. A. Van Ziffle, A. L. DeFranco, and C. A. Lowell, "Hyperactivated MyD88 signaling in dendritic cells, through specific deletion of Lyn kinase, causes severe autoimmunity and inflammation, " Proceedings of theNationalAcademy of Sciences of the United States of America, vol. 110, no. 35, pp. E3311-E3320, 2013.
90. W. Liu and X. Zhang, "Receptor activator of nuclear factor-B ligand (RANKL)/RANK/osteoprotegerin system in bone and other tissues (Review), " Molecular Medicine Reports, vol. 11, no. 5, pp. 3212-3218, 2015.
91. E. Salt and L. Crofford, "Rheumatoid arthritis: new treatments, better outcomes, " Nurse Practitioner, vol. 37, no. 11, pp. 16-22, 2012.
92. M. Sen, K. Lauterbach, H. El-Gabalawy, G. S. Firestein, M. Corr, and D. A. Carson, "Expression and function of wingless and frizzled homologs in rheumatoid arthritis, " Proceedings of the National Academy of Sciences of the United States of America, vol. 97, no. 6, pp. 2791-2796, 2000.
93. Z. Zhong, N. J. Ethen, and B. O. Williams, "WNT signaling in bone development and homeostasis, " Wiley Interdisciplinary Reviews: Developmental Biology, vol. 3, no. 6, pp. 489-500, 2014.
94. C.-G. Miao, Y.-Y. Yang, X. He et al., "Wnt signaling pathway in rheumatoid arthritis, with special emphasis on the different roles in synovial inflammation and bone remodeling, " Cellular Signalling, vol. 25, no. 10, pp. 2069-2078, 2013.
95. D. Daoussis and A. P. Andonopoulos, "The emerging role of Dickkopf-1 in bone biology: is it the main switch controlling bone and joint remodeling?" Seminars in Arthritis and Rheumatism, vol. 41, no. 2, pp. 170-177, 2011.
96. D. E. Furst and P. Emery, "Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets, " Rheumatology, vol. 53, no. 9, Article IDket414, pp. 1560-1569, 2014.
97. J. Braun and J. Sieper, "Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-therapy and other novel approaches, " Arthritis Research, vol. 4, no. 5, pp. 307-321, 2002.
98. D. Diarra, M. Stolina, K. Polzer et al., "Dickkopf-1 is a master regulator of joint remodeling, " Nature Medicine, vol. 13, no. 2, pp. 156-163, 2007.
99. S. Uderhardt, D. Diarra, J. Katzenbeisser et al., "Blockade of Dickkopf (DKK)-1 induces fusion of sacroiliac joints, " Annals of the Rheumatic Diseases, vol. 69, no. 3, pp. 592-597, 2010.
100. Z. Hu, M. Xu, Q. Li et al., "Adalimumab significantly reduces inflammation and serum DKK-1 level but increases fatty deposition in lumbar spine in active ankylosing spondylitis, " International Journal of Rheumatic Diseases, vol. 15, no. 4, pp. 358-365, 2012.
101. S. E. Ross, N. Hemati, K. A. Longo et al., "Inhibition of adipogenesis by Wnt signaling, " Science, vol. 289, no. 5481, pp. 950-953, 2000.
102. S.-R. Kwon, M.-J. Lim, C.-H. Suh et al., "Dickkopf-1 level is lower in patients with ankylosing spondylitis than in healthy people and is not influenced by anti-tumor necrosis factor therapy, " Rheumatology International, vol. 32, no. 8, pp. 2523-2527, 2012.
103. G. R. Heiland, H. Appel, D. Poddubnyy et al., "High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patientswith ankylosing spondylitis, " Annals of the Rheumatic Diseases, vol. 71, no. 4, pp. 572-574, 2012.
104. Y. J. Deng, Z. X. Huang, C. J. Zhou et al., "Gene profiling involved in immature CD4+ T lymphocyte responsible for systemic lupus erythematosus, " Molecular Immunology, vol. 43, no. 9, pp. 1497-1507, 2006.
105. Y.-J. Sheng, J.-P. Gao, J. Li et al., "Follow-up study identifies two novel susceptibility loci PRKCB and 8p11. 21 for systemic lupus erythematosus, " Rheumatology, vol. 50, no. 4, pp. 682-688, 2011.
106. L. Long, Y. Liu, S. Wang et al., "Dickkopf-1 as potential biomarker to evaluate bone erosion in systemic lupus erythematosus, " Journal of Clinical Immunology, vol. 30, no. 5, pp. 669-675, 2010.
107. A. T. Naito, T. Sumida, S. Nomura et al., "Complement C1q activates canonical Wnt signaling and promotes aging-related phenotypes, " Cell, vol. 149, no. 6, pp. 1298-1313, 2012.
108. Y. Tan, D. Song, L.-H. Wu, F. Yu, and M.-H. Zhao, "Serum levels and renal deposition of C1q complement component and its antibodies reflect disease activity of lupus nephritis, " BMC Nephrology, vol. 14, no. 1, article 63, 2013.
109. D. Wang, S. Huang, X. Yuan et al., "The regulation of the Treg/Th17 balance by mesenchymal stem cells in human systemic lupus erythematosus, " Cellular and Molecular Immunology, 2015.
110. T. Yamaza, A. Kentaro, C. Chen et al., "Immunomodulatory properties of stemcells fromhuman exfoliated deciduous teeth, " Stem Cell Research andTherapy, vol. 1, no. 1, article 5, 2010.
111. Y.-S. Lee, K.-A. Lee, H.-B. Yoon et al., "The Wnt inhibitor secreted frizzled-related protein 1 (sFRP1) promotes human Th17 differentiation, " European Journal of Immunology, vol. 42, no. 10, pp. 2564-2573, 2012.
112. H. S. Bandukwala and A. Rao, "'Nurr'ishing Treg cells: Nr4a transcription factors control Foxp3 expression, " Nature immunology, vol. 14, no. 3, pp. 201-203, 2013.
113. H. Kitagawa, W. J. Ray, H. Glantschnig et al., "A regulatory circuit mediating convergence between Nurr1 transcriptional regulation and Wnt signaling, " Molecular and Cellular Biology, vol. 27, no. 21, pp. 7486-7496, 2007.
114. E. W. Choi, H. W. Lee, S. Shin et al., "Comparative efficacies of long-term serial transplantation of syngeneic, allogeneic, xenogeneic, or CTLA4Ig overproducing xenogeneic adipose tissuederived mesenchymal stem cells on murine systemic lupus erythematosus, " Cell Transplantation, 2015.
115. N. Che, X. Li, L. Zhang et al., "Impaired B cell inhibition by lupus bone marrow mesenchymal stem cells is caused by reduced CCl2 expression, " Journal of Immunology, vol. 193, no. 10, pp. 5306-5314, 2014.
116. S. Fujimaki, T. Wakabayashi, T. Takemasa et al., "The regulation of stem cell aging byWnt signaling, " Histology and Histopathology, vol. 30, no. 12, pp. 1411-1430, 2015.
117. E. Leah, "Connective tissue diseases: epigenetic silencing ofWnt inhibition in systemic sclerosis, " Nature Reviews Rheumatology, vol. 9, no. 7, p. 384, 2013.
118. C. Bergmann, A. Akhmetshina, C. Dees et al., "Inhibition of glycogen synthase kinase 3 induces dermal fibrosis by activation of the canonical Wnt pathway, " Annals of the Rheumatic Diseases, vol. 70, no. 12, pp. 2191-2198, 2011.
119. A. Distler, L. Deloch, J. Huang et al., "Inactivation of tankyrases reduces experimental fibrosis by inhibiting canonical Wnt signalling, " Annals of the Rheumatic Diseases, vol. 72, no. 9, pp. 1575-1580, 2013.
120. M. Königshoff, M. Kramer, N. Balsara et al., "WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis, "The Journal of Clinical Investigation, vol. 119, no. 4, pp. 772-787, 2009.
121. E. G. Quetglas, "Update on pathogenesis and predictors of response of therapeutic strategies used in inflammatory bowel disease, " World Journal of Gastroenterology, vol. 21, no. 44, p. 12519, 2015.
122. M. M. H. Claessen, M. E. I. Schipper, B. Oldenburg, P. D. Siersema, G. J. A. Offerhaus, and F. P. Vleggaar, "WNT-pathway activation in IBD-associated colorectal carcinogenesis: potential biomarkers for colonic surveillance, " Cellular Oncology, vol. 32, no. 4, pp. 303-310, 2010.
123. T. Tuller, S. Atar, E. Ruppin, M. Gurevich, and A. Achiron, "Common and specific signatures of gene expression and protein-protein interactions in autoimmune diseases, " Genes and Immunity, vol. 14, no. 2, pp. 67-82, 2013.
124. G. Rogler, "Chronic ulcerative colitis and colorectal cancer, " Cancer Letters, vol. 345, no. 2, pp. 235-241, 2014.
125. K. R. Hughes, F. Sablitzky, and Y. R. Mahida, "Expression profiling of Wnt family of genes in normal and inflammatory bowel disease primary human intestinal myofibroblasts and normal human colonic crypt epithelial cells, " Inflammatory Bowel Diseases, vol. 17, no. 1, pp. 213-220, 2011.
126. J. You, A. V. Nguyen, C. G. Albers, F. Lin, and R. F. Holcombe, "Wnt pathway-related gene expression in inflammatory bowel disease, " Digestive Diseases and Sciences, vol. 53, no. 4, pp. 1013-1019, 2008.
127. H. van Dekken, J. C. Wink, K. J. Vissers et al., "Wnt pathwayrelated gene expression duringmalignant progression in ulcerative colitis, " ActaHistochemica, vol. 109, no. 4, pp. 266-272, 2007.
128. M. Gersemann, E. F. Stange, and J. Wehkamp, "From intestinal stem cells to inflammatory bowel diseases, " World Journal of Gastroenterology, vol. 17, no. 27, pp. 3198-3203, 2011.
129. J. Cosín-Roger, D. Ortiz-Masiá, S. Calatayud et al., "M2 macrophages activate WNT signaling pathway in epithelial cells: relevance in ulcerative colitis, " PLoS ONE, vol. 8, no. 10, Article ID e78128, 2013.
130. A. Sato, H. Kayama, K. Shojima et al., "The Wnt5a-Ror2 axis promotes the signaling circuit between interleukin-12 and interferon-in colitis, " Scientific Reports, vol. 5, Article ID10536, 2015.
131. J. Cosín-Roger, D. Ortiz-Masiá, S. Calatayud, C. Hernández, J. V. Esplugues, and M. D. Barrachina, "The activation of Wnt signaling by a STAT6-dependent macrophage phenotype promotesmucosal repair inmurine IBD, "Mucosal Immunology, 2015.
132. M. Dhir, E. A. Montgomery, S. C. Glöckner et al., "Epigenetic regulation of WNT signaling pathway genes in inflammatory bowel disease (IBD) associated neoplasia, " Journal of Gastrointestinal Surgery, vol. 12, no. 10, pp. 1745-1753, 2008.
133. A. Serafino, N. Moroni, M. Zonfrillo et al., "WNT-pathway components as predictivemarkers useful for diagnosis, prevention and therapy in inflammatory bowel disease and sporadic colorectal cancer, " Oncotarget, vol. 5, no. 4, pp. 978-992, 2014.
134. Y. Xing, X. Chen, Y. Cao, J. Huang, X. Xie, and Y. Wei, "Expression of Wnt and Notch signaling pathways in inflammatory bowel disease treated with mesenchymal stem cell transplantation: evaluation in a rat model, " Stem Cell Research and Therapy, vol. 6, no. 1, article 101, 2015.
135. J. Huelsken and W. Birchmeier, "New aspects of Wnt signaling pathways in higher vertebrates, " Current Opinion in Genetics and Development, vol. 11, no. 5, pp. 547-553, 2001.
136. A. B. Coda, V. Qafalijaj Hysa, K. Seiffert-Sinha, and A. A. Sinha, "Peripheral blood gene expression in alopecia areata reveals molecular pathways distinguishing heritability, disease and severity, " Genes and Immunity, vol. 11, no. 7, pp. 531-541, 2010.
137. S. Reddy, T. Andl, A. Bagasra et al., "Characterization of Wnt gene expression in developing and postnatal hair follicles and identification ofWnt5a as a target of Sonic hedgehog in hair follicle morphogenesis, " Mechanisms of Development, vol. 107, no. 1-2, pp. 69-82, 2001.
138. G. S. Eisenbarth, "Type 1 diabetes: molecular, cellular and clinical immunology, " Advances in Experimental Medicine and Biology, vol. 552, pp. 306-310, 2004.
139. X. He, W. Han, S.-X. Hu, M.-Z. Zhang, J.-L. Hua, and S. Peng, "Canonical Wnt signaling pathway contributes to the proliferation and survival in porcine pancreatic stem cells (PSCs), " Cell and Tissue Research, vol. 362, no. 2, pp. 379-388, 2015.
140. G. D. Weinstein, J. L. McCullough, and P. A. Ross, "Cell kinetic basis for pathophysiology of psoriasis, " Journal of Investigative Dermatology, vol. 85, no. 6, pp. 579-583, 1985.
141. M. Romanowska, A. Evans, D. Kellock et al., "Wnt5a exhibits layer-specific expression in adult skin, is upregulated in psoriasis, and synergizes with type 1 interferon, " PLoS ONE, vol. 4, no. 4, Article ID e5354, 2009.
142. J. Han, Y. Lee, K.-H. Yeom, Y.-K. Kim, H. Jin, and V. N. Kim, "The Drosha-DGCR8 complex in primary microRNA processing, " Genes and Development, vol. 18, no. 24, pp. 3016-3027, 2004.
143. S. K. Singh, M. Pal Bhadra, H. J. Girschick, and U. Bhadra, "MicroRNAs-micro in size butmacro in function, " FEBS Journal, vol. 275, no. 20, pp. 4929-4944, 2008.
144. L. T. Jeker and R. Marone, "Targeting microRNAs for immunomodulation, " Current Opinion in Pharmacology, vol. 23, pp. 25-31, 2015.
145. J. L. Marques-Rocha, M. Samblas, F. I. Milagro, J. Bressan, J. A. Martínez, and A. Marti, "Noncoding RNAs, cytokines, and inflammation-related diseases, " The FASEB Journal, vol. 29, no. 9, pp. 3595-3611, 2015.
146. S. Mahmood, A. Bhatti, N. A. Syed, andP. John, "ThemicroRNA regulatory network: a far-reaching approach to the regulate the Wnt signaling pathway in number of diseases, " Journal of Receptors and Signal Transduction, vol. 36, no. 3, pp. 310-318, 2016.
147. K. M. Pauley and S. Cha, "miRNA-146a in rheumatoid arthritis: a new therapeutic strategy, " Immunotherapy, vol. 3, no. 7, pp. 829-831, 2011.
148. D. Liu, H. Zhao, S. Zhao, and X. Wang, "MicroRNA expression profiles of peripheral blood mononuclear cells in patients with systemic lupus erythematosus, " Acta Histochemica, vol. 116, no. 5, pp. 891-897, 2014.
149. I. Györy, S. Boller, R. Nechanitzky et al., "Transcription factor Ebf1 regulates differentiation stage-specific signaling, proliferation, and survival of B cells, "Genes andDevelopment, vol. 26, no. 7, pp. 668-682, 2012.
150. S. Luo, Y. Liu, G. Liang et al., "The role of microrna-1246 in the regulation of B cell activation and the pathogenesis of systemic lupus erythematosus, " Clinical Epigenetics, vol. 7, no. 1, article 24, 2015.
151. J. Stanczyk, D. M. Leslie Pedrioli, F. Brentano et al., "Altered expression of microRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis, " Arthritis and Rheumatism, vol. 58, no. 4, pp. 1001-1009, 2008.
152. B. Qin, F. Huang, Y. Liang, Z. Yang, and R. Zhong, "Analysis of altered microRNA expression profiles in peripheral blood mononuclear cells frompatients with primary biliary cirrhosis, " Journal of Gastroenterology and Hepatology, vol. 28, no. 3, pp. 543-550, 2013.